Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of pneumococcal antibodies and memory B-cell function after conjugate vaccination in chronic lymphocytic leukemia
2009-012099-29Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 cohorts), sponsored by Tampere University Hospital. Primary endpoint: Serum antibody response one month after vaccination. Started Apr 2009; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2009-012099-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012099-29.